Phathom Pharmaceuticals PHAT
NASDAQ PHAT
$5.35 +0.02 (+0.38%)
As of: Nov 10, 2026 · 1:40 PM EST

Phathom Pharmaceuticals (PHAT) Receivables - Net (2023 - 2026)

Updated

Analysis

Phathom Pharmaceuticals (PHAT) Receivables - Net (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn
10 Phathom Pharmaceuticals 460.12 Mn -229.24 Mn 66.36 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 107.60 Mn
Jun 30, 2026 97.42 Mn
Mar 31, 2026 80.72 Mn
Dec 31, 2025 76.11 Mn
Sep 30, 2025 55.79 Mn
Jun 30, 2025 51.26 Mn
Mar 31, 2025 36.36 Mn
Dec 31, 2024 35.65 Mn
Sep 30, 2024 21.05 Mn
Jun 30, 2024 10.88 Mn
Mar 31, 2024 3.88 Mn
Dec 31, 2023 1.30 Mn
API Access

Phathom Pharmaceuticals Receivables - Net API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-net&ticker=PHAT&period=max&api_key=YOUR_API_KEY